NEW YORK — Lawyers for Sean 'Diddy' Combs labeled the prosecution against the hip-hop star as "sexist and puritanical" on Tuesday, saying nine recordings of sex acts considered important ...

Sean McLain is a reporter for The Wall Street Journal based in Los Angeles, covering EV startups like Rivian and Lucid and Japanese and Korean auto makers. Prior to moving to Los Angeles, Sean was ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for ...

Absci Co. (NASDAQ:ABSI – Get Free Report) has been assigned an average recommendation of “Buy” from the six research firms that are presently covering the stock, Marketbeat.com reports.

“At Absci, we’re constantly pushing the boundaries of innovation to bring better biologics to patients faster,” said Sean McClain, Founder and CEO of Absci. “By ...

“At Absci, we’re constantly pushing the boundaries of innovation to bring better biologics to patients faster,” said Sean McClain, Founder and CEO of Absci. “By combining Absci’s AI de novo design ...

“At Absci, we’re constantly pushing the boundaries of innovation to bring better biologics to patients faster,” said Sean McClain, Founder and CEO of Absci. “By combining Absci’s AI de ...

“At Absci, we’re constantly pushing the boundaries of innovation to bring better biologics to patients faster,” said Sean McClain, Founder and CEO of Absci. “By combining Absci’s AI de ...

VANCOUVER, Wash. and PARIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to ...